Oxybutynin Chloride
- Product NDC
- 71335-1494
- 11-digit product format
- 713351494
- Labeler code
- 71335
- Product ID
- 71335-1494_d51ceac8-b32e-4a2e-97f8-4a4ccbbf616a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxybutynin Chloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209335
- Marketing category
- ANDA
- Marketing start
- 2017-12-22
- Substance
- OXYBUTYNIN CHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209335-001 | OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209335-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209335-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209335-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Preferred Pharmaceuticals Inc. | 0e002fe8-fa3f-4a7d-84df-0c6e031e6ae4 | 2026-01-15 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9c8ced4b-94de-4df8-bea3-b42b8846b769 | 2025-03-12 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0c021aad-97a3-4404-a11e-cdd2ec731c6b | 2025-03-07 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | 2025-01-30 | Warnings, Adverse reactions | 209335 ANDA209335 71335-1494 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | KVK-Tech, Inc. | f99fdfe8-a980-4a72-bc99-aa2ce0bdfd86 | 2024-12-06 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 39a2d144-0c10-4aec-9fa4-0adc24b332eb | 2024-06-03 | Warnings, Adverse reactions | 209335 ANDA209335 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxybutynin Chloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYBUTYNIN CHLORIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| L9F3D9RENQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 863664 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3544f362-07fc-93b1-457b-1fba00be087a | Product name | 8 | 20230316 |
| 4daffbf2-44c8-ca46-d284-5db69e1e6ef4 | Product name | 8 | 20210525 |
| 982338c6-c45c-b6b4-1452-14b01fbdf98d | Product name | 2 | 20180801 |
| 054197ba-7ed3-0ddb-321e-dbb51c0fe9b6 | Product name | 2 | 20171212 |
| 3544f362-07fc-93b1-457b-1fba00be087a | Product name | 2 | 20171212 |
| 8b00ae7e-01f2-f83c-632e-edfc23808364 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1494-1 | Oxybutynin Chloride | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 71335-1494-2 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 5 | |
| 71335-1494-3 | Oxybutynin Chloride | 20 in 1 BOTTLE | TABLET | 20 | 5 | |
| 71335-1494-4 | Oxybutynin Chloride | 60 in 1 BOTTLE | TABLET | 60 | 5 | |
| 71335-1494-5 | Oxybutynin Chloride | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 71335-1494-6 | Oxybutynin Chloride | 42 in 1 BOTTLE | TABLET | 42 | 5 | |
| 71335-1494-7 | Oxybutynin Chloride | 15 in 1 BOTTLE | TABLET | 15 | 5 | |
| 71335-1494-8 | Oxybutynin Chloride | 180 in 1 BOTTLE | TABLET | 180 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1494 | OXYBUTYNIN CHLORIDE TABLET [BRYANT RANCH PREPACK] | 5 | Current NDC, Legacy NDC, 8 package rows | 20250224_f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 863664 | oxyBUTYnin chloride 5 MG Oral Tablet | PSN | f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | 5 |
| 863664 | oxybutynin chloride 5 MG Oral Tablet | SCD | f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71335-1494-1 | 71335149401 | 30 TABLET in 1 BOTTLE (71335-1494-1) | 30 tablet | 2020-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-2 | 71335149402 | 100 TABLET in 1 BOTTLE (71335-1494-2) | 100 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-3 | 71335149403 | 20 TABLET in 1 BOTTLE (71335-1494-3) | 20 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-4 | 71335149404 | 60 TABLET in 1 BOTTLE (71335-1494-4) | 60 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-5 | 71335149405 | 90 TABLET in 1 BOTTLE (71335-1494-5) | 90 tablet | 2020-07-07 | 0000-00-00 | No | No | Current |
| 71335-1494-6 | 71335149406 | 42 TABLET in 1 BOTTLE (71335-1494-6) | 42 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-7 | 71335149407 | 15 TABLET in 1 BOTTLE (71335-1494-7) | 15 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |
| 71335-1494-8 | 71335149408 | 180 TABLET in 1 BOTTLE (71335-1494-8) | 180 tablet | 2025-01-30 | 0000-00-00 | No | No | Current |